{"schema_version":"1","generated_at":"2026-11-01T13:22:53.640Z","data_as_of":"2026-10-29","url":"https://www.findmykol.com/kol/anne-marie-wills","json_url":"https://www.findmykol.com/kol/anne-marie-wills/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"anne-marie-wills","name":"Anne-Marie Wills","credential":"MD, MPH","title":"Associate Professor of Neurology","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"institution":"Massachusetts General Hospital","institution_url":"https://www.findmykol.com/institution/massachusetts-general-hospital","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1922082858","orcid":"0000-0002-0901-4711","openalex":"A5062713774"},"summary":"Anne-Marie Wills is Associate Professor of Neurology at Massachusetts General Hospital. OpenAlex indexes 123 publications with 4,060 citations (h-index 31); ClinicalTrials.gov lists 11 registered studies with this person as an investigator.","overview":{"text":"Anne-Marie Wills, MD MPH, is Associate Professor of Neurology at Massachusetts General Hospital. The public record shows 123 publications with 4,060 citations (h-index 31), centered on Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Dementia and Cognitive Impairment Research. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 3 companies, 3 NIH-funded awards (2010–2026).","bullets":["Most recent indexed publication: 2026 · Neurology","Top research focus: Parkinson's Disease Mechanisms and Treatments","11 registered trials on ClinicalTrials.gov","Open Payments reporting from 3 companies"],"generated_at":"2026-10-31"},"focus":{"indications":[{"label":"Supranuclear Palsy, Progressive","therapeutic_area":"Ophthalmology","trials":6,"topics":0,"strength":18},{"label":"Paralysis","therapeutic_area":"Neurology","trials":6,"topics":0,"strength":18},{"label":"Parkinson's Disease","therapeutic_area":"Neurology","trials":5,"topics":1,"strength":16},{"label":"Alzheimer's / Dementia","therapeutic_area":"Neurology","trials":2,"topics":2,"strength":8},{"label":"ALS","therapeutic_area":"Neurology","trials":2,"topics":1,"strength":7},{"label":"Motor Neuron Disease","therapeutic_area":"Neurology","trials":2,"topics":0,"strength":6},{"label":"Multiple System Atrophy","therapeutic_area":"Neurology","trials":2,"topics":0,"strength":6},{"label":"Atrophy","therapeutic_area":"Epidemiology","trials":2,"topics":0,"strength":6},{"label":"Dementia","therapeutic_area":"Neurology","trials":2,"topics":0,"strength":6},{"label":"Corticobasal Degeneration","therapeutic_area":"Neurology","trials":2,"topics":0,"strength":6},{"label":"Pain","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Weight Loss","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Cachexia","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Huntington Disease","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Lewy Body Disease","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Frontotemporal Dementia","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Frontotemporal Lobar Degeneration","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Hypotension","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Hypotension, Orthostatic","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Multiple system atrophy (MSA) with orthostatic hypotension","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3}],"research_topics":["Parkinson's Disease Mechanisms and Treatments","Neurological disorders and treatments","Dementia and Cognitive Impairment Research","Amyotrophic Lateral Sclerosis Research","Alzheimer's disease research and treatments"],"works_with":{"total":7,"shown":3,"withheld":4,"rows":[{"name":"Genentech USA, Inc.","trials":0,"payments":5,"mentions":5},{"name":"Massachusetts General Hospital","trials":5,"payments":0,"mentions":5},{"name":"Adam Boxer","trials":3,"payments":0,"mentions":3}]}},"scholarship":{"works_count":123,"cited_by_count":4060,"h_index":31,"i10_index":57,"pubmed_count":13,"latest_activity_year":2026,"source":"works"},"trials":{"count":11,"shown":3,"withheld":8,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07569367","title":"A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"BioSensics","source_url":"https://clinicaltrials.gov/study/NCT07569367","trial_url":"https://www.findmykol.com/trial/NCT07569367"},{"nct":"NCT07264283","title":"The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31","phase":"PHASE2","status":"ENROLLING_BY_INVITATION","role":"Investigator","sponsor":"Adam Boxer","source_url":"https://clinicaltrials.gov/study/NCT07264283","trial_url":"https://www.findmykol.com/trial/NCT07264283"},{"nct":"NCT07240805","title":"Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"BioSensics","source_url":"https://clinicaltrials.gov/study/NCT07240805","trial_url":"https://www.findmykol.com/trial/NCT07240805"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2022,"last":2025},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"Genentech USA, Inc.","program_year":2025,"amount_usd":4384.79,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1922082858"},{"payer":"Genentech, Inc.","program_year":2024,"amount_usd":1010,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1922082858"},{"payer":"Genentech, Inc.","program_year":2023,"amount_usd":1515,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1922082858"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1922082858","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":85,"classes_total":11,"classes":[{"class":"Aromatic Amino Acid Decarboxylation Inhibitor","setting":"prescribed","share_pct":46.7,"drugs":[{"name":"Carbidopa-Levodopa","share_pct":52.9},{"name":"Rytary","share_pct":23.2},{"name":"Carbidopa-Levodopa Er","share_pct":18.9},{"name":"Carbidopa","share_pct":4.9}],"max_beneficiaries":null},{"class":"Cholinesterase Inhibitor","setting":"prescribed","share_pct":10.1,"drugs":[{"name":"Donepezil Hcl","share_pct":82},{"name":"Rivastigmine","share_pct":18}],"max_beneficiaries":48}]},{"area":"Genitourinary & hormones","share_pct":5.5,"classes_total":2,"classes":[{"class":"beta3-Adrenergic Agonist","setting":"prescribed","share_pct":4.1,"drugs":[{"name":"Myrbetriq","share_pct":71},{"name":"Gemtesa","share_pct":29}],"max_beneficiaries":null},{"class":"alpha-Adrenergic Blocker","setting":"prescribed","share_pct":1.4,"drugs":[{"name":"Tamsulosin Hcl","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":3.4,"classes_total":1,"classes":[{"class":"Beta blocker","setting":"prescribed","share_pct":3.4,"drugs":[{"name":"Propranolol Hcl","share_pct":56.1},{"name":"Propranolol Hcl Er","share_pct":43.9}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":94.5,"facility_pct":5.5},"source":"medicare"},"funding":{"award_count":3,"fiscal_years":{"first":2010,"last":2026},"rows_total":12,"shown":3,"withheld":9,"rows":[{"project":"R44AG080861","title":"Phase IIB: A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration Syndromes","fiscal_year":2026,"amount_usd":1000082,"organization":"BIOSENSICS, LLC","source_url":"https://reporter.nih.gov/quickSearch/R44AG080861"},{"project":"R01AG085029","title":"The Progressive Supranuclear Palsy Clinical Trial Platform (PTP)","fiscal_year":2025,"amount_usd":14499067,"organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/R01AG085029"},{"project":"UF1AG094587","title":"Digital Health Technologies for Monitoring Motor Function in Progressive Supranuclear Palsy and Dementia with Lewy Bodies","fiscal_year":2025,"amount_usd":5174076,"organization":"BIOSENSICS, LLC","source_url":"https://reporter.nih.gov/quickSearch/UF1AG094587"}],"source":"grants"},"publications":{"total":13,"shown":5,"withheld":8,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Proximity to Water Pollutant Facilities and Risk of Incident Progressive Supranuclear Palsy: Nested Case-Control Study of the UK Biobank.","year":2026,"journal":"Neurology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42950187/","status":"verified"},{"title":"Pre-Diagnostic Factors Associated with Coding-Based Incident Multiple System Atrophy: A Nested Case-Control Study of the UK Biobank.","year":2026,"journal":"Movement disorders : official journal of the Movement Disorder Society","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42502215/","status":"verified"},{"title":"PD GENEration: An International Parkinson's Disease Genetic Research Study.","year":2026,"journal":"medRxiv : the preprint server for health sciences","types":["Journal Article","Preprint"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42238438/","status":"verified"},{"title":"Levodopa Efficacy and GLP-1 Receptor Agonists.","year":2026,"journal":"Movement disorders clinical practice","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41821320/","status":"verified"},{"title":"Risk Factors for the Diagnosis of Progressive Supranuclear Palsy in the UK Biobank.","year":2026,"journal":"Movement disorders : official journal of the Movement Disorder Society","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42481001/","status":"verified"}],"most_cited":{"total":123,"shown":5,"withheld":118,"rows":[{"title":"miRNA malfunction causes spinal motor neuron disease","year":2010,"cited_by_count":327,"type":"article","source_url":"https://doi.org/10.1073/pnas.1006151107"},{"title":"Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis","year":2011,"cited_by_count":293,"type":"article","source_url":"https://doi.org/10.1002/mus.22114"},{"title":"Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial","year":2014,"cited_by_count":267,"type":"article","source_url":"https://doi.org/10.1016/s0140-6736(14)60222-1"},{"title":"Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease","year":2015,"cited_by_count":240,"type":"article","source_url":"https://doi.org/10.1001/jama.2015.120"},{"title":"Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis","year":2011,"cited_by_count":199,"type":"review","source_url":"https://doi.org/10.1002/ana.22611"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Michael A. Schwarzschild","coauthored_works":24},{"name":"Alexander Y. Pantelyat","coauthored_works":21},{"name":"Albert Y. Hung","coauthored_works":16}],"source":"works"},"presence":{"owned_accounts":{"total":2,"shown":2,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/anne-marie-wills-md","status":"verified"},{"platform":"linkedin","url":"https://www.linkedin.com/in/anne-marie-wills-48540023","status":"verified"}]},"mentions":{"total":7,"shown":3,"rows":[{"url":"https://www.facebook.com/alsassociation/posts/reminder-join-us-tomorrow-march-25-at-200-pm-et-for-healthy-eating-in-als-jane-h/10156401515071775/","platform":"facebook","status":"provisional"},{"url":"https://advances.massgeneral.org/contributors/contributor.aspx?id=1387","platform":"other","status":"verified"},{"url":"https://medicalxpress.com/news/2026-03-subtle-health-supranuclear-palsy-years.html","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":4,"shown":4,"rows":[{"value":"MD, Columbia University College of Physicians & Surgeons, 2001","source_url":"https://www.massgeneralbrigham.org/en/doctors/w/annemarie-wills-3001610","status":"verified","collected_at":"2026-10-31"},{"value":"MPH, Harvard School of Public Health","source_url":"https://www.massgeneralbrigham.org/en/doctors/w/annemarie-wills-3001610","status":"verified","collected_at":"2026-10-31"},{"value":"BA, Princeton University","source_url":"https://www.massgeneralbrigham.org/en/doctors/w/annemarie-wills-3001610","status":"verified","collected_at":"2026-10-31"},{"value":"Board certification: Neurology, American Board of Psychiatry and Neurology","source_url":"https://www.massgeneralbrigham.org/en/doctors/w/annemarie-wills-3001610","status":"verified","collected_at":"2026-10-31"}]},"roles":{"total":2,"shown":2,"rows":[{"value":"Steering Committee, PSP Study Group of the International Parkinson and Movement Disorder Society","source_url":"https://www.massgeneralbrigham.org/en/doctors/w/annemarie-wills-3001610","status":"verified","collected_at":"2026-10-31"},{"value":"Steering Committee, Progressive Supranuclear Palsy Study Group (PSP)","source_url":"https://www.movementdisorders.org/MDS/About/Committees--Other-Groups/Study-Groups/Progressive-Supranuclear-Palsy-Study-Group-PSP.htm","status":"verified","collected_at":"2026-10-31"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Harvard Medical School","source_url":"https://www.massgeneralbrigham.org/en/doctors/w/annemarie-wills-3001610","status":"verified","collected_at":"2026-10-31"}]},"media":{"total":6,"shown":3,"rows":[{"value":"Golf and Parkinson's Disease feature (Golf & Health)","source_url":"https://www.golfandhealth.org/news/golf-and-parkinsons-disease-dr-anne-marie-wills/","status":"provisional","collected_at":"2026-10-31"},{"value":"Co-author quoted in MedicalXpress coverage of PSP research","source_url":"https://medicalxpress.com/news/2026-03-subtle-health-supranuclear-palsy-years.html","status":"provisional","collected_at":"2026-10-31"},{"value":"Mass General Brigham research spotlight on PSP risk factors (co-lead and senior author)","source_url":"https://news.massgeneralbrigham.org/en/risk-factors-for-developing-progressive-supranuclear-palsy","status":"verified","collected_at":"2026-10-31"}]},"public_positions":{"total":4,"shown":2,"rows":[{"value":"Director, CurePSP Center of Care, Massachusetts General Hospital","source_url":"https://advances.massgeneral.org/contributors/contributor.aspx?id=1387","status":"verified","collected_at":"2026-10-31"},{"value":"Principal Investigator, CurePSP Genetics Program","source_url":"https://www.massgeneralbrigham.org/en/doctors/w/annemarie-wills-3001610","status":"verified","collected_at":"2026-10-31"}]}},"similar":[{"name":"Keith Flaherty","slug":"keith-flaherty","institution":"Massachusetts General Hospital","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/keith-flaherty","json_url":"https://www.findmykol.com/kol/keith-flaherty/profile.json"},{"name":"James Januzzi","slug":"james-januzzi","institution":"Massachusetts General Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/james-januzzi","json_url":"https://www.findmykol.com/kol/james-januzzi/profile.json"},{"name":"Maurizio Fava","slug":"maurizio-fava","institution":"Massachusetts General Hospital","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/maurizio-fava","json_url":"https://www.findmykol.com/kol/maurizio-fava/profile.json"},{"name":"Steven Greenberg","slug":"steven-greenberg","institution":"Massachusetts General Hospital","specialty":"Neurology","url":"https://www.findmykol.com/kol/steven-greenberg","json_url":"https://www.findmykol.com/kol/steven-greenberg/profile.json"},{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":8,"payments":2,"funding":9,"publications":8,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-31"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-31"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2022 to 2025","collected_at":"2026-10-31"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-31"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-31"}},"methodology_url":"https://www.findmykol.com/about#methodology"}